Effect of the Contraceptive Sponge on Chlamydial Infection, Gonorrhea, and Candidiasis: A Comparative Clinical Trial

JAMA: The Journal of the American Medical Association

Volumn 257, Issue 17, 1987, Pages 2308-2312

  Rosenberg, Michael J ^a   Rojanapithayakorn, Wiwat ^b,c   Feldblum, Paul J ^a   Higgins, James E ^a  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b Department of Disease Control   (United States)

^c American Social Health Association   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONOXINOL 9;

CANDIDIASIS; CHLAMYDIACEAE; CLINICAL ARTICLE; CONTRACEPTIVE SPONGE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; FEMALE GENITAL SYSTEM; FUNGUS; GONORRHEA; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; MALE GENITAL SYSTEM; METHODOLOGY; PREVENTION; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; THAILAND; VAGINITIS;

CANDIDIASIS, VULVOVAGINAL; CHLAMYDIA INFECTIONS; CLINICAL TRIALS; COMPARATIVE STUDY; CONTRACEPTIVE DEVICES, FEMALE; EPIDEMIOLOGIC METHODS; FEMALE; GONORRHEA; HUMAN; NONOXYNOL; POLYETHYLENE GLYCOLS; PROSTITUTION; RANDOM ALLOCATION; SPERMATOCIDAL AGENTS; SUPPORT, U.S. GOV'T, NON-P.H.S.; THAILAND;

EID: 0023176027     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1987.03390170064029     Document Type: Article

References (24)

1. Pratt WF, Mosher WD, Bachrach CA, et al.: Understanding U.S. Fertility: Findings From the National Survey of Family Growth Cycle III. Washington, DC, Population Reference Bureau, 1984.
2. Singh B, Cutler JC, Utidjian HMD: Studies on development of a vaginal preparation providing both prophylaxis against venereal disease, other genital infections and contraception: II. In vitro effect of contraceptive preparations on Treponema pallidum and Neisseria gonorrhoeae. Br J Vener Dis 1972;48:57-64.
3. Singh B, Cutler JC, Utidjian HMD: Studies on development of a vaginal preparation providing both prophylaxis against venereal disease, other genital infections and contraception: III. In vitro effect of vaginal contraceptive and selected vaginal preparations on Candida albicans and Trichomonas vaginalis. Contraception 1972;5:401-411.
4. Singh B, Postic B, Cutler JC: Virucidal effect of certain chemical contraceptives on type 2 herpes virus. Am J Obstet Gynecol 1976;126:422-425.
5. Cowan ME, Cree GE: A note on the susceptibility of N. gonorrhoeae to contraceptive agent Nonyl-P. Br J Vener Dis 1973;49:65-66.
6. Allicotti GM, Jensen RH, Berger KL, et al.: Prophylactic properties of the Today contraceptive sponge. Read before the annual meeting of the Association of Planned Parenthood Professionals, Seattle, Oct 18, 1985.
7. Hicks DR, Martin LS, Getchell JP, et al.: Inactivation of HTLV-III/LAV—infected cultures of normal human lymphocytes by nonoxynol-9 in vitro. Lancet 1985;2:1422-1423.
8. Jick H, Hannan MT, Stergachis A, et al.: Vaginal spermicides and gonorrhea. JAMA 1982;248: 1619-1621.
9. Austin H, Louv WC, Alexander J: A casecontrol study of spermicides and gonorrhea. JAMA 1984;251:2822-2824.
10. Quinn RW, O’Reilly KR: Contraceptive practices of women attending the sexually transmitted disease clinic in Nashville, Tennessee. Sex Transm Dis 1985;12:99-102.
11. Sanders LL, Harrison HR, Washington AE: Treatment of sexually transmitted chlamydial infections. JAMA 1986;255:1750-1756.
12. Benes S, McCormack WM: Inhibition of growth of Chlamydia trachomatis by nonoxynol-9 in vitro. Antimicrob Agents Chemother 1985;27: 724-726.
13. Kelly JP, Reynolds RB, Stagno S, et al.: In vitro activity of the spermicide nonoxynol-9 against Chlamydia trachomatis. Antimicrob Agents Chemother 1985;27:760-762.
14. Kappus EW, Quinn TC: The spermicide nonoxynol-9 does not inhibit Chlamydia trachomatis in vitro. Sex Transm Dis 1986;13:134-137.
15. Rosenberg MJ, Feldblum PJ, Rojanapithayakorn W, et al.: The contraceptive sponge’s protection against chlamydia and gonorrhea. Sex Transm Dis, in press.
16. Ehret JM, Judson FN, Biddle JW: Gonorrhea, in Wentworth BB, Judson FN (eds): Laboratory Methods for the Diagnosis of Sexually Transmitted Diseases. Washington, DC, American Public Health Association, 1984, pp 43-79.
17. Cutler SJ, Ederer F: Maximum utilization of the life table method in analyzing survival. J Chronic Dis 1958;6:699-712.
18. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170.
19. Cox DR: Regression models and life tables (with discussion). J Roy Statist Soc Series B 1972; 34:187-202.
20. Handsfield HH: Gonorrhea and uncomplicated gonococcal infection, in Holmes KK, Mardh P-A, Sparling PF, et al. (eds): Sexually Transmitted Diseases. New York, McGraw-Hill International Book Co, 1984, pp 205-220.
21. Thompson SE, Washington AE: Epidemiology of sexually transmitted Chlamydia trachomatis infections. Epidemiol Rev 1983;5:96-123.
22. Friberg J, Confino E, Suarez M, et al.: Chlamydia trachomatis attached to spermatozoa recovered from the peritoneal cavity of patients with salpingitis. J Reprod Med 1987;32:120-122.
23. James-Holmquist AN, Swanson J, Buchanan TM, et al.: Differential attachment by piliated and nonpiliated Neisseria gonorrhoeae to human sperm. Infect Immun 1974;9:897-902.
24. Stone KR, Grimes DA, Magder LS: Personal protection against sexually transmitted diseases. Am J Obstet Gynecol 1986;155:180-188.